Found: 1
Select item for more details and to access through your institution.
Phase II study of 'high-dose' celecoxib and metronomic 'low-dose' cyclophosphamide and methotrexate in patients with relapsed and refractory lymphoma.
- Published in:
- Ecancermedicalscience, 2009, v. 3, p. 1, doi. 10.3332/ecancer.2009.144
- By:
- Publication type:
- Article